Catalyst Wire Dossier Catalyst Wire Dossier

Autologous PBMC modulated with IFNt

Autologous peripheral blood mononuclear cells modulated with IFNt · Nadezhda Women's Health Hospital
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Autologous PBMC modulated with IFNt, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome [NA]

See pricing